Tracking infections and quality of life in blood cancer patients
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Infections clinical trials.
This study uses a smartphone or web app to track infections and quality of life in people with multiple myeloma or chronic lymphocytic leukemia who have a weakened immune system. The goal is to create a better screening tool for infections and understand how the disease and treatment affect daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have access to a smartphone, tablet, or computer to use the study app or website
- You speak German
- You have been diagnosed with multiple myeloma or chronic lymphocytic leukemia
- You have a weakened immune system (due to recurrent infections, low infection-fighting proteins, or low white blood cell counts)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This study tests a digital tool to help doctors keep an eye on patients with chronic myeloid leukemia who have stopped their treatment. If you join, you'll use the tool to share health updates, which might help you stay safely off treatment.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This study follows people with multiple sclerosis over time using a smartphone app and clinic visits. It aims to better understand the disease and improve care.
This trial tests a digital app designed to help people with multiple myeloma (a blood cancer) manage their quality of life and symptoms. The study wants to see if using this app on a phone or computer can help patients feel better and stay connected to their care.
Hear when a new Chronic Lymphocytic Leukaemia (CLL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.